Received Apr 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
the patient became sick; This non-serious case was reported by a nurse via other manufacturer and described the occurrence of sickness in a patient who received MMR (Priorix) for prophylaxis. In MAR-2025, the patient received Priorix. On 08-APR-2025, less than 2 months after receiving Priorix, the patient experienced sickness (Verbatim: the patient became sick). The outcome of the sickness was not reported. It was unknown if the reporter considered the sickness to be related to Priorix and Priorix Pre-Filled Syringe Device. It was unknown if the company considered the sickness to be related to Priorix and Priorix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date : 08-APR-2025 Nurse reported that one month ago the patient received GlaxoSmithKline (GSK) version of vaccine (Priorix) and on the day of reporting the patient became sick came into the office. No additional adverse events were reported. No further information was provided. No product quality complaint (PQC) was provided.